Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Alto Neuroscience Inc.

    NYSE: ANRO · Real-Time Price · USD
    2.29
    -0.02 (-0.87%)
    At close: Jun 17, 2025, 3:43 PM

    Alto Neuroscience Statistics

    Share Statistics

    Alto Neuroscience has 27.07M shares outstanding. The number of shares has increased by 0.7% in one year.

    Shares Outstanding

    n/a
    		 27.07M

    Shares Change (YoY)

    n/a
    		 0.7%

    Shares Change (QoQ)

    n/a
    		 0.38%

    Owned by Institutions (%)

    n/a
    		 82.31%

    Shares Floating

    n/a
    		 21.49M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,971

    FTD / Avg. Volume

    n/a
    		 0.78%

    Short Selling Information

    The latest short interest is 2.94M, so 10.87% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.94M

    Short % of Shares Out

    n/a
    		 10.87%

    Short % of Float

    n/a
    		 13.8%

    Short Ratio (days to cover)

    n/a
    		 16.22

    Valuation Ratios

    The PE ratio is -1.69 and the forward PE ratio is -0.88. Alto Neuroscience's PEG ratio is -0.02.

    PE Ratio

    n/a
    		 -1.69

    Forward PE

    n/a
    		 -0.88

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 1.3

    PB Ratio

    n/a
    		 0.69

    P/FCF Ratio

    n/a
    		 -2.1

    PEG Ratio

    n/a
    		 -0.02
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Alto Neuroscience.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 16.92, with a Debt / Equity ratio of 0.11.

    Current Ratio

    n/a
    		 16.92

    Quick Ratio

    n/a
    		 16.92

    Debt / Equity

    n/a
    		 0.11

    Debt / EBITDA

    n/a
    		 -0.25

    Debt / FCF

    n/a
    		 -0.34

    Interest Coverage

    n/a
    		 49.9

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-808,302.63

    Employee Count

    n/a
    		 76

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -79.1% in the last 52 weeks. The beta is 1.93, so Alto Neuroscience's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.93

    52-Week Price Change

    n/a
    		 -79.1%

    50-Day Moving Average

    n/a
    		 2.41

    200-Day Moving Average

    n/a
    		 5.19

    Relative Strength Index (RSI)

    n/a
    		 41.42

    Average Volume (20 Days)

    n/a
    		 253,239

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -68.61M

    Net Income

    n/a
    		 -61.43M

    EBITDA

    n/a
    		 -68.61M

    EBIT

    n/a
    		 -62.81M

    Earnings Per Share (EPS)

    n/a
    		 -2.5
    Full Income Statement

    Balance Sheet

    The company has 168.23M in cash and 16.94M in debt, giving a net cash position of 151.28M.

    Cash & Cash Equivalents

    n/a
    		 168.23M

    Total Debt

    n/a
    		 16.94M

    Net Cash

    n/a
    		 151.28M

    Retained Earnings

    n/a
    		 -138.4M

    Total Assets

    n/a
    		 171.91M

    Working Capital

    n/a
    		 156.27M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -47.42M and capital expenditures -2.08M, giving a free cash flow of -49.5M.

    Operating Cash Flow

    n/a
    		 -47.42M

    Capital Expenditures

    n/a
    		 -2.08M

    Free Cash Flow

    n/a
    		 -49.5M

    FCF Per Share

    n/a
    		 -2.01
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    ANRO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ANRO is $10, which is 332.9% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $10

    Price Target Difference

    n/a
    		 332.9%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 6
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -0.02

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist